Govt Job: For M.Pharm, M.Sc at NIPER

NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specialisations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010.

Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialisation in Medical Devices.

Post : Junior Research Fellow JRF (1 Post)

Applications are invited from eligible candidates for JRF position in the project funded by DST- SERB. The position is temporary in nature.

Project File No. : SRG/2020/000658/CS

Project Title : Merging Vinylic and Allylic C–H Bonds Activation under Single-Component Serial Palladium Catalysis: Development of Topoisomerase I (ToP I) – Histone Deacetylase (HDAC) Dual Inhibitors

Engagement Period : 4-5 months

Salary : As per DST-SERB norms

Qualification
M.Pharm or Equivalent (with specialization in Medicinal Chemistry / Pharmaceutical Chemistry) / M.Sc. or equivalent (with specialization in Medicinal Chemistry / Organic / Pharmaceutical Chemistry) as evidenced from published papers in standard refereed journals.

PG degree with 60% marks for GN/OBC (55% for SC/ST/PH) from UGC recognized University/ Institute.

Age Limit : 28 years on the date of application, with relaxation to SC/ST/OBC candidates as per Government of India norms.

Job Profile : For this project, the candidate should be: a) Proficient in basic organic chemistry, green chemistry, and analytical techniques. b) Should able to work on transition metal catalysis including but not limited to C- H bond activation protocol

Terms and Conditions
• Interested candidates may send their CV in attached format and cover letter via email to Registrar, NIPER-A (registrar@niperahm.res.in) with a copy to PI at Email : Dr. Dinesh Kumar (dineshk@niperahm.res.in) on or before 14th March, 2023.

Please write “Application for DST-SRF” in the subject line of the email.

• Shortlisted candidates would be intimated by e-mail for the interview (Online/Offline).

• Candidates should bring the printouts of the application form with original and self-attested copies of all the supporting documents at the time of the interview.

• No canvassing in any form will be entertained.

• No TA/DA will be paid for attending the interview

Last date: on or before 14th March, 2023

Related Posts

  • Pharma
  • May 21, 2025
  • 120 views
Gland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announced

Gland Pharma Q4 Results: Pharma company Gland Pharma on Tuesday, May 20, posted a weak set of numbers for the fourth quarter of the financial year 2024-25 (Q4 FY25), recording…

  • Pharma
  • May 21, 2025
  • 235 views
Medical shop operating without licence raided, illegal stock seized

A medical shop in Alwal was raided by officials of the Telangana Drugs Control Administration (DCA) following a tip-off about illegal sale of medicines. During the inspection, officials discovered that…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announced

Gland Pharma Q4 results: Profit dips 3% YoY to ₹187 crore; 1800% dividend announced

Medical shop operating without licence raided, illegal stock seized

Medical shop operating without licence raided, illegal stock seized

Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

Zydus Wellness posts 30% profit growth in FY25, Q4 net sales up 17% YoY

Lupin to boost complex generics in US, EU; eyes chronic growth in India

Lupin to boost complex generics in US, EU; eyes chronic growth in India

Growth Triggers Line Up for Divi’s Labs

Growth Triggers Line Up for Divi’s Labs

From generic drugs to vaccines, Indian pharma industry is transforming lives worldwide

From generic drugs to vaccines, Indian pharma industry is transforming lives worldwide